巴约纳关于便失禁的共识声明. 西班牙结肠直肠病学协会
Javier Cerdán Miguel1, Antonio Arroyo Sebastián2, Antonio Codina Cazador3
1Unidad de Coloproctología, Hospital Viamed Santa Elena, Madrid, Spain.
Cirugia espanola
|January 19, 2024
概括
便失禁 (FI) 是一个重要的健康问题. 这一共识为FI的诊断和治疗提供了基于证据的指导,强调了个性化的患者护理.
科学领域:
- 结肠直肠病学 (coloproctology) 是一种大肠直肠病学.
- 胃肠病学 胃肠病学
- 基于证据的医学基于证据的医学.
背景情况:
- 便失禁 (FI) 对个人和医疗保健系统构成重大挑战.
- 对FI存在许多诊断和治疗选择,但科学证据各不相同.
- 需要标准化,基于证据的指导方针来管理FI.
研究的目的:
- 制定一个共识指南,用于诊断和治疗便失禁.
- 为医疗保健专业人员提供基于科学证据的FI管理框架.
- 促进便失禁患者个性化治疗决策.
主要方法:
- 西班牙结肠直肠病学协会 (AECP) 召集专家,以达成共识.
- 用名义小组技术方法来制定共识.
- 证据水平和建议等级遵循了牛津证据医学中心的标准.
主要成果:
- 该共识为FI的诊断测试和治疗选择提供了指导.
- 它强调了考虑患者特征和医疗团队经验的重要性.
- 专家建议被整合到指南中,用于实际应用.
结论:
- 这种共识是卫生专业人员管理便失禁的宝贵指南.
- 它倡导基于证据的实践和FI管理中的个性化患者护理.
- 该指南旨在改善结果并减少便失禁的负担.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
147
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
147
01:21Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
208
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
208
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
163
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
163
01:29Drugs for Treatment of Ulcerative Colitis in IBD
142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142